Table 1.
Sex-specific polypectomy rates according to patient and endoscopist colonoscopy indications (n = 2134)
| Colonoscopy indication1 |
Male |
Female |
||
| Screening PRs % (95%CI) | Non-screening PRs % (95%CI) | Screening PRs % (95%CI) | Non-screening PRs % (95%CI) | |
| Patient | 32.4 (23.8-41.8) | 34.4 (27.0-41.9) | 19.4 (13.1-25.4) | 22.3 (16.3-28.6) |
| Endoscopista | 30.2 (22.3-38.9) | 37.3 (29.7-45.3) | 16.6 (11.0-22.7) | 26.3 (19.4-33.3) |
| Endoscopistb | 31.4 (23.5-39.7) | 36.1 (28.2-44.4) | 17.6 (11.7-23.7) | 25.2 (18.1-32.4) |
1
Screening colonoscopy indications defined as follows: (1) Patient: colonoscopy performed in individuals without a history of either gastrointestinal conditions in the past 12 mo or large bowel symptoms in the past 6 mo; (2) Endoscopista: colonoscopy performed in asymptomatic individuals or those with a family history of colorectal cancer; and (3) Endocopistb: colonoscopy performed in asymptomatic individuals or those with a family history of colorectal cancer; or reported as confirmatory colonoscopy (performed to follow-up on a positive screen). PRs: Polypectomy rates.